Stephanie Krebs
Vermögen: - $ am 31.07.2026
Vermögen: - $ am 31.07.2026
Stephanie Krebs is currently Chief Business Officer at Sensei Biotherapeutics, Inc. since 2023.
Formerly, Ms. Krebs was Chief Business Officer at SNIPR Biome ApS from 2022 to 2023.
Education includes graduate studies at The Johns Hopkins University, undergraduate studies at Rochester Christian University, and an MBA from the University of Rochester Simon Business School.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.03.2026 | 0 ( -.--% ) | - $ | 31.07.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| FAETH THERAPEUTICS, INC. | Corporate Officer/Principal | 01.11.2023 |
| Unternehmen | Position | Ende |
|---|---|---|
SNIPR Biome ApS
SNIPR Biome ApS Pharmaceuticals: MajorHealth Technology Develops bacterial composition to provide treatment for diabetes to cancer | Corporate Officer/Principal | 01.10.2023 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
Rochester Christian University
Rochester Christian University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Johns Hopkins University
The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Rochester Simon Business School
University of Rochester Simon Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SNIPR Biome ApS
SNIPR Biome ApS Pharmaceuticals: MajorHealth Technology Develops bacterial composition to provide treatment for diabetes to cancer | Health Technology |
Sensei Biotherapeutics, Inc.
Sensei Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company, which develops immunotherapies for cancers and infectious disease | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen